Drug-Target Information | ||||||||
---|---|---|---|---|---|---|---|---|
Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
dalfampridine | potassium voltage-gated channel subfamily a member 1 | small molecule | NA | drugbank , DGIDB | Multiple Sclerosis[MeSHID:D009103] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.54 | approved | antagonist |
dalfampridine | potassium voltage-gated channel subfamily a member 1 | small molecule | NA | drugbank , DGIDB | Multiple Sclerosis[MeSHID:D009103] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.54 | approved | antagonist,blocker |
dalfampridine | potassium voltage-gated channel subfamily a member 10 | small molecule | NA | drugbank , DGIDB | Multiple Sclerosis[MeSHID:D009103] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.63 | approved | antagonist,blocker |
dalfampridine | potassium voltage-gated channel subfamily a member 2 | small molecule | NA | drugbank , DGIDB | Multiple Sclerosis[MeSHID:D009103] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.49 | approved | antagonist,blocker |
dalfampridine | potassium voltage-gated channel subfamily a member 3 | small molecule | NA | drugbank , DGIDB | Multiple Sclerosis[MeSHID:D009103] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.49 | approved | antagonist,blocker |
dalfampridine | potassium voltage-gated channel subfamily a member 4 | small molecule | NA | drugbank , DGIDB | Multiple Sclerosis[MeSHID:D009103] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.59 | approved | antagonist,blocker |
dalfampridine | potassium voltage-gated channel subfamily a member 5 | small molecule | NA | drugbank , DGIDB | Multiple Sclerosis[MeSHID:D009103] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.23 | approved | antagonist,blocker |
dalfampridine | potassium voltage-gated channel subfamily a member 6 | small molecule | NA | drugbank , DGIDB | Multiple Sclerosis[MeSHID:D009103] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.74 | approved | antagonist,blocker |
dalfampridine | potassium voltage-gated channel subfamily a member 7 | small molecule | NA | drugbank , DGIDB | Multiple Sclerosis[MeSHID:D009103] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.37 | approved | antagonist,blocker |
dalfampridine | potassium voltage-gated channel subfamily b member 1 | small molecule | NA | drugbank , DGIDB | Multiple Sclerosis[MeSHID:D009103] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.74 | approved | antagonist,blocker |
dalfampridine | potassium voltage-gated channel subfamily b member 2 | small molecule | NA | drugbank , DGIDB | Multiple Sclerosis[MeSHID:D009103] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.89 | approved | antagonist,blocker |
dalfampridine | potassium voltage-gated channel subfamily c member 1 | small molecule | NA | drugbank , DGIDB | Multiple Sclerosis[MeSHID:D009103] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.74 | approved | antagonist,blocker |
dalfampridine | potassium voltage-gated channel subfamily c member 2 | small molecule | NA | drugbank , DGIDB | Multiple Sclerosis[MeSHID:D009103] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.74 | approved | antagonist,blocker |
dalfampridine | potassium voltage-gated channel subfamily c member 3 | small molecule | NA | drugbank , DGIDB | Multiple Sclerosis[MeSHID:D009103] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.74 | approved | antagonist,blocker |
dalfampridine | potassium voltage-gated channel subfamily d member 1 | small molecule | NA | drugbank , DGIDB | Multiple Sclerosis[MeSHID:D009103] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
1.11 | approved | antagonist,blocker |
dalfampridine | potassium voltage-gated channel subfamily d member 2 | small molecule | NA | drugbank , DGIDB | Multiple Sclerosis[MeSHID:D009103] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.74 | approved | antagonist,blocker |
dalfampridine | potassium voltage-gated channel subfamily d member 3 | small molecule | NA | drugbank , DGIDB | Multiple Sclerosis[MeSHID:D009103] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.74 | approved | antagonist,blocker |
click here to return to the previous page |